Amanda Wagner Gee is an associate director with the FasterCures team of the Milken Institute, working on health equity and diversity in clinical trials and infrastructure for community-based clinical research. Her expertise is in areas related to clinical and preclinical research design and conduct. Prior to joining FasterCures, she worked at the National Academies on the Forum for Drug Discovery, Development, and Translation on projects related to the clinical trials enterprise, diversity and inclusion in clinical trials, real-world data and real-world evidence, and patient- and participant-engagement. She began her career as a research scientist working on drug discovery with the Harvard Stem Cell Institute and the National Center for Advancing Translational Sciences at the NIH. She received her master’s degree in cell biology from Duke University.